<DOC>
	<DOCNO>NCT01609010</DOCNO>
	<brief_summary>This randomize , open-label study compare efficacy safety MabThera/Rituxan ( rituximab ) alone , combination Roferon-A ( interferon alfa-2a ) patient follicular CD20+ low-grade lymphoma . Patients randomize receive either MabThera/Rituxan 375 mg/m2 intravenously weekly 4 week Roferon-A 3 MIU/day subcutaneously Week 1 follow 4.5 MIU/day sc Weeks 2-5 plus MabThera/Rituxan 375 mg/m2 weekly iv Weeks 3-6 . Patients response receive additional cycle treatment . The anticipated time study treatment 6 month .</brief_summary>
	<brief_title>A Study MabThera/Rituxan ( Rituximab ) Alone Combination With Roferon-A Patients With Follicular Other CD20+ Low-Grade ( Indolent ) Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Adult patient &gt; 18 year age CD20+ lowgrade ( indolent ) lymphoma follicular marginal zone type , small lymphocytic lymphoma without BCLL phenotype , indolent lymphoma otherwise specify Stage II ( bulky disease ) , III , IV lymphoma No previous chemotherapy maximum 6 month chlorambucil cyclophosphamide Indication treatment : symptomatic enlarge lymph node , spleen lymphoma manifestation , progression &gt; 6 month lymphadenopathy splenomegaly , anemia thrombocytopenia decrease hemoglobin platelet due lymphoma , general symptom ( weight loss , night sweat fever ) WHO performance status 02 Prior treatment rituximab interferon BCLL , mantle cell lymphoma , lymphoplasmacytic lymphoma ( Waldenstroem 's disease ) , central nervous system lymphoma Indolent lymphoma transform aggressive lymphoma Indolent lymphoma bulky tumor require urgent therapy Prior malignancy , except nonmelanoma skin tumor , situ cervical cancer , curative surgery &gt; 5 year ago Positive HIV infection Uncontrolled asthma allergy require corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>